Aurobindo Pharma Limited (AUROPHARMA.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
As of 01:42PM IST. Market open.
| Previous close | 1,207.60 |
| Open | 1,214.05 |
| Bid | 1,209.05 x 0 |
| Ask | 1,209.15 x 0 |
| Day's range | 1,204.05 - 1,226.00 |
| 52-week range | 708.85 - 1,292.10 |
| Volume | |
| Avg. volume | 1,621,670 |
| Market cap | 707.675B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 22.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.50 (0.37%) |
| Ex-dividend date | 20 Feb 2024 |
| 1y target est | N/A |
- Investing.com
Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead
Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA surged by an impressive 68%, surpassing both Goldman Sachs (NYSE:GS)' projections and those of the broader market. The EBITDA margin also exceeded forecasts, reaching 22.3%, which is 101 basis points higher than Goldman Sachs' estimate.
© 2024 Yahoo. All rights reserved.